Posted By: Jennie Gunnerson
Sigenics is proud to be a partner in the groundbreaking NIH-sponsored clinical trial of the Intracortical Visual Prosthesis (ICVP) project.
Phil Troyk, President and CEO of Sigenics, is the prinicipal investigator leading 8 institutions in this team effort to implant Sigenics-designed microchips into the brains of people with blindness, with the goal of restoring some of their vision.
For more details, and to listen to Phil describe the project in his own words, please click on the below link:
Intracortical Visual Prosthesis Trial to begin